Treatment of intraoperatively detected peritoneal carcinomatosis of colorectal origin with cytoreductive surgery and intraperitoneal chemotherapy. 2018

Aras Emre Canda, and Cigdem Arslan, and Cem Terzi, and Selman Sokmen, and Tugba Yavuzsen, and Sevda Ozkardesler, and Mehtat Unlu, and Funda Obuz, and Mehmet Fuzun
Department of Surgery, Dokuz Eylul University School of Medicine, Balcova, 35340, Izmir, Turkey. emre.canda@deu.edu.tr.

BACKGROUND Diagnosis of peritoneal carcinomatosis (PC) may be missed by preoperative imaging. We are presenting our experience with incidentally detected PC of colorectal origin treated with cytoreductive surgery (CRS) and intraperitoneal chemotherapy (IPC) at the same operation. METHODS Between January 2010 and September 2016, 19 patients underwent CRS and IPC due to incidentally detected PC of colorectal origin. Data were analyzed from a prospectively collected database. RESULTS The median age was 59 (29-78). In three patients, PC was diagnosed during emergency surgery. The primary tumor was located in the rectum (three patients; one with recurrent disease), left colon (9 patients), and right colon (7 patients). All patients underwent CRS and IPC, and one patient operated laparoscopically. Median peritoneal cancer index (PCI) was 5 (range, 3-14), and complete cytoreduction (CC-0) was achieved in 14 patients. After CRS, 8 patients received early postoperative intraperitoneal chemotherapy (EPIC), 7 patients received hyperthermic intraperitoneal chemotherapy (HIPEC), and 4 patients received both HIPEC and EPIC. The median hospital stay was 9 (6-29) days. Postoperative complications occurred in 6 patients. There was no postoperative mortality. Median follow-up was 40.2 (12-94) months. Five-year overall survival was 63.2%. Estimated mean survival time is longer in patients who underwent complete cytoreduction compared to patients having CC-1 or CC-2 cytoreduction (87.7 vs. 20.3 months; p < 0.001). CONCLUSIONS Cytoreductive surgery and IPC can be performed safely in patients with intraoperatively detected incidental PC of colorectal origin.

UI MeSH Term Description Entries
D006979 Hyperthermia, Induced Abnormally high temperature intentionally induced in living things regionally or whole body. It is most often induced by radiation (heat waves, infra-red), ultrasound, or drugs. Fever Therapy,Hyperthermia, Local,Hyperthermia, Therapeutic,Thermotherapy,Induced Hyperthermia,Therapeutic Hyperthermia,Therapy, Fever,Local Hyperthermia
D008207 Lymphatic Metastasis Transfer of a neoplasm from its primary site to lymph nodes or to distant parts of the body by way of the lymphatic system. Lymph Node Metastasis,Lymph Node Metastases,Lymphatic Metastases,Metastasis, Lymph Node
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009361 Neoplasm Invasiveness Ability of neoplasms to infiltrate and actively destroy surrounding tissue. Invasiveness, Neoplasm,Neoplasm Invasion,Invasion, Neoplasm
D010478 Chemotherapy, Cancer, Regional Perfusion Neoplasm drug therapy involving an extracorporeal circuit with temporary exclusion of the tumor-bearing area from the general circulation during which high concentrations of the drug are perfused to the isolated part. Cancer Chemotherapy, Regional Perfusion,Perfusion Cancer Chemotherapy, Regional,Regional Perfusion Antineoplastic Chemotherapy,Isolation Perfusion Cancer Chemotherapy,Regional Perfusion Cancer Chemotherapy
D010534 Peritoneal Neoplasms Tumors or cancer of the PERITONEUM. Peritoneal Carcinomatosis,Peritoneal Surface Malignancy,Carcinomatosis, Peritoneal,Malignancy, Peritoneal Surface,Neoplasm, Peritoneal,Peritoneal Carcinomatoses,Peritoneal Neoplasm,Peritoneal Surface Malignancies,Surface Malignancy, Peritoneal
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D011446 Prospective Studies Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group. Prospective Study,Studies, Prospective,Study, Prospective
D003131 Combined Modality Therapy The treatment of a disease or condition by several different means simultaneously or sequentially. Chemoimmunotherapy, RADIOIMMUNOTHERAPY, chemoradiotherapy, cryochemotherapy, and SALVAGE THERAPY are seen most frequently, but their combinations with each other and surgery are also used. Multimodal Treatment,Therapy, Combined Modality,Combined Modality Therapies,Modality Therapies, Combined,Modality Therapy, Combined,Multimodal Treatments,Therapies, Combined Modality,Treatment, Multimodal,Treatments, Multimodal

Related Publications

Aras Emre Canda, and Cigdem Arslan, and Cem Terzi, and Selman Sokmen, and Tugba Yavuzsen, and Sevda Ozkardesler, and Mehtat Unlu, and Funda Obuz, and Mehmet Fuzun
February 2014, Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico,
Aras Emre Canda, and Cigdem Arslan, and Cem Terzi, and Selman Sokmen, and Tugba Yavuzsen, and Sevda Ozkardesler, and Mehtat Unlu, and Funda Obuz, and Mehmet Fuzun
June 2014, Harefuah,
Aras Emre Canda, and Cigdem Arslan, and Cem Terzi, and Selman Sokmen, and Tugba Yavuzsen, and Sevda Ozkardesler, and Mehtat Unlu, and Funda Obuz, and Mehmet Fuzun
November 2005, Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico,
Aras Emre Canda, and Cigdem Arslan, and Cem Terzi, and Selman Sokmen, and Tugba Yavuzsen, and Sevda Ozkardesler, and Mehtat Unlu, and Funda Obuz, and Mehmet Fuzun
July 1992, AORN journal,
Aras Emre Canda, and Cigdem Arslan, and Cem Terzi, and Selman Sokmen, and Tugba Yavuzsen, and Sevda Ozkardesler, and Mehtat Unlu, and Funda Obuz, and Mehmet Fuzun
September 2011, Deutsche medizinische Wochenschrift (1946),
Aras Emre Canda, and Cigdem Arslan, and Cem Terzi, and Selman Sokmen, and Tugba Yavuzsen, and Sevda Ozkardesler, and Mehtat Unlu, and Funda Obuz, and Mehmet Fuzun
April 2011, Il Giornale di chirurgia,
Aras Emre Canda, and Cigdem Arslan, and Cem Terzi, and Selman Sokmen, and Tugba Yavuzsen, and Sevda Ozkardesler, and Mehtat Unlu, and Funda Obuz, and Mehmet Fuzun
April 2019, Harefuah,
Aras Emre Canda, and Cigdem Arslan, and Cem Terzi, and Selman Sokmen, and Tugba Yavuzsen, and Sevda Ozkardesler, and Mehtat Unlu, and Funda Obuz, and Mehmet Fuzun
February 1995, Annals of surgery,
Aras Emre Canda, and Cigdem Arslan, and Cem Terzi, and Selman Sokmen, and Tugba Yavuzsen, and Sevda Ozkardesler, and Mehtat Unlu, and Funda Obuz, and Mehmet Fuzun
September 2007, Ugeskrift for laeger,
Aras Emre Canda, and Cigdem Arslan, and Cem Terzi, and Selman Sokmen, and Tugba Yavuzsen, and Sevda Ozkardesler, and Mehtat Unlu, and Funda Obuz, and Mehmet Fuzun
June 2004, The British journal of surgery,
Copied contents to your clipboard!